Ms contin and Micro-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ms contin (morphine sulfate) and Micro-k (potassium chloride). Common drug interactions include bone disorder among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Ms contin and Micro-k. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Ms contin?

Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,289 Ms contin users. Check the latest studies of Ms contin.

What is Micro-k?

Micro-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,895 Micro-k users. Check the latest studies of Micro-k.



On Jul, 21, 2026

49 people who take Ms contin and Micro-k together, and have interactions are studied.

Ms contin and Micro-k drug interactions.

What are the common drug interactions of Ms Contin and Micro-K, by gender? *:

female:

  1. Bone disorder
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Pain in jaw
  4. Anxiety
  5. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  6. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  7. Oedema peripheral (superficial swelling)
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Osteonecrosis (death of bone)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

male:

  1. Arthralgia (joint pain)
  2. Prostate cancer
  3. Intervertebral disc degeneration (spinal disc degeneration)
  4. Intervertebral disc protrusion (spinal disc protrusion)
  5. Light chain analysis increased
  6. Myelitis transverse (a neurological condition consisting of an inflammatory process of the spinal cord)
  7. Myofascial pain syndrome (a painful condition that affects the muscles and the sheath of the tissue)
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Osteonecrosis of jaw (death of bone of jaw)
  10. Osteoporosis (bones weak and more likely to break)

What are the common drug interactions of Ms Contin and Micro-K, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anxiety
  2. Bacterial infection
  3. Erythema (redness of the skin)
  4. Impaired healing
  5. Inflammation
  6. Pain in jaw
  7. Pyrexia (fever)
  8. Tenderness (pain or discomfort when an affected area is touched)
  9. Bone pain
  10. Decreased interest

50-59:

  1. Metastatic renal cell carcinoma (spreadable kidney cell tumour)
  2. Renal mass (mass in kidney)
  3. Toxoplasma serology positive
  4. Cardiomegaly (increased size of heart than normal)
  5. Depressed level of consciousness
  6. Gait disturbance
  7. Hepatic steatosis (fatty liver disease)
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Arthralgia (joint pain)
  10. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)

60+:

  1. Hypoproteinaemia (too little prolactin circulating in the blood)
  2. Hypoxia (low oxygen in tissues)
  3. Oedema peripheral (superficial swelling)
  4. Pain in extremity
  5. Staphylococcal infection (an infection with staphylococcus bacteria)
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  8. Neutropenia (an abnormally low number of neutrophils)
  9. Pyrexia (fever)
  10. Bacteraemia (presence of bacteria in the blood)

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 17 people, 34.69%
  2. Nausea (feeling of having an urge to vomit): 11 people, 22.45%
  3. Stress And Anxiety: 10 people, 20.41%
  4. Multiple Myeloma (cancer of the plasma cells): 10 people, 20.41%
  5. Breast Cancer: 9 people, 18.37%
  6. Oedema (fluid collection in tissue): 8 people, 16.33%
  7. High Blood Cholesterol: 8 people, 16.33%
  8. Gout (uric acid crystals building up in the body): 8 people, 16.33%
  9. Asthma: 8 people, 16.33%
  10. Peripheral Neuropathy (damage to nerves of the peripheral nervous system): 7 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Ms contin and Micro-k?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ms contin and Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ms contin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micro-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate and potassium chloride (the active ingredients of Ms contin and Micro-k, respectively), and Ms contin and Micro-k (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: